About this trial
Chronic low back pain (CLBP) is a leading cause of disability worldwide and affects a large proportion of working-age individuals. Cortical reorganization in CLBP, particularly within the sensorimotor cortex, has been shown to negatively influence sensory acuity and motor control. The neuroplasticity underlying this reorganization may enhance the effectiveness of sensorimotor retraining therapies that involve specific stimulus features targeting somatosensory cortical regions.
This randomized controlled trial will include three groups: a device-assisted sensory acuity training group, a manual sensory acuity training group, and a control group receiving conventional physiotherapy. In this study, device-assisted sensory acuity training will be delivered using a standardized vibrotactile interface that presents controlled stimuli and records participant responses. The intervention will be structured to target sensory acuity components similar to those addressed in manual training.
Accordingly, the structured training protocol will include:
* localization training to improve detection of stimulus location, * orientation discrimination to identify stimulus direction, * temporal acuity training to distinguish timing differences between tactile stimuli and * graphesthesia training to improve recognition of shapes or letters drawn on the skin through tactile input.
The primary aim of this study is to evaluate sensory acuity in individuals with CLBP and to determine the effects of a structured manual and technology-based sensory acuity training program, combined with conventional physiotherapy, on pain intensity (VAS), lumbar two-point discrimination, and a composite sensory acuity score.
We hypothesize that adding manual and technology-based structured sensory acuity training (SAT) program to a conventional physiotherapy regimen including motor control exercises will support central nervous system reorganization, improve sensory profiles, and lead to improvements in pain-related variables, disability, and quality of life.
Through this structured SAT program, we aim to provide an approach that evaluates and trains multiple dimensions of sensory acuity in CLBP, including localization, orientation, and temporal discrimination.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 25-45 years
No spinal fracture or acute disc herniation
Pain duration ≥ 3 months
Pain intensity ≥ 4/10
Disqualifiers
Serious spinal pathologies (lumbar stenosis, spondylolisthesis, tumor, infection, metastasis, osteoporotic fracture, severe structural deformities, inflammatory arthritis)
Conditions with radicular involvement or neurological deficits (sciatica, nerve root compression)
Systemic or neurological diseases (diabetes mellitus, neuromuscular diseases, serious central or peripheral nervous system diseases, epilepsy)
Mental disorders
Trial design
Parallel
Treatments tested in this trial
Technology-Based Sensory Acuity Training Group (T-SATG)
DeviceThe vibrotactile stimuli will be delivered according to a predefined weekly progression. In Week 1, high-intensity vibrations will be applied with a duration of 500 ms and an inter-stimulus interval of 1 second. In Week 2, medium-intensity vibrations will be delivered with a duration of 500 ms and a 500-ms inter-stimulus interval. In Week 3, medium-intensity vibrations will be delivered with a duration of 200 ms and a 200-ms inter-stimulus interval, and in Week 4, low-intensity vibrations will be applied with a duration of 100 ms and a 100-ms inter-stimulus interval. This structured progression is designed to ensure a gradual increase in task difficulty and to standardize the vibrotactile training across participants.
Control Group (CG)
Other interventionThe MCE program will follow a progressive approach targeting activation of the transversus abdominis and multifidus muscles. It will begin with basic exercises emphasizing isolated contractions and progress to more complex movements involving co-activation of both muscles, including bridging and quadruped exercises. As part of the PE component, participants will receive fundamental information regarding spinal health, neutral spine posture, and appropriate movement strategies for daily activities. Guidance will be provided on ergonomics, including lifting techniques, workspace organization, and methods to reduce mechanical load on the lower back. The program will also support self-care by promoting regular physical activity, appropriate pacing during flare-ups, adequate rest, and healthy lifestyle habits.
Manual Sensory Acuity Training Group (M-SATG)
Other interventionTo progressively increase difficulty, Semmes-Weinstein monofilaments with thick and thin tips will be used to vary stimulus pressure. Stimulus duration will advance weekly: week 1 - thick tip 5 s, week 2 - thick tip 2 s, week 3 - thin tip 5 s, week 4 - thin tip 2 s, with a stopwatch ensuring standardization and fixed intervals between stimuli. All sensory acuity tasks (localization, orientation, temporal acuity, and graphesthesia) will be delivered using randomized sets generated by random.org to prevent habituation. Responses will be recorded weekly to track progress. An adhesive 16-hole grid template will be placed between the last rib and sacrum on each participant before each session.
Treatment groups
Trial outcomes
Primary outcomes
Visual Analog Scale (VAS)
In order to evaluate the pain levels of the participants, the average pain intensity in the last 7 days will be evaluated with the Visual Analog Scale (VAS).
Two-Point Discrimination Test (TPDT)
TPDT skill levels of individuals with CLI will be measured using a commercially available mechanical aesthesiometer (Baseline, 12-1480 Aesthesiometer).
Sensory Acuity Composite Score
Localization, orientation, and temporal acuity accuracy (%) will be calculated by taking the average value of the sum of the levels. Evaluations will be made using the thick end of the monofilament. Each application will be performed in two sets of 20 repetitions in random order, each set including location, direction, and number of stimuli. Localization accuracy will be assessed using a locognosy test, which measures the percentage of correct responses by touching areas numbered 1 to 16 on a 4x4 grid, with participants pointing to the correct point on the figure.
Roland Morris Disability Questionnaire (RMDQ)
The Roland Morris Disability Questionnaire (RMDQ), consisting of 24 questions focusing on regular activities of daily living, will be used to assess participants' disability levels. The total score ranges from 0 to 24, with higher scores reflecting increasing disability and scores exceeding 14 indicating severe disability.
Secondary outcomes
Pain Pressure Threshold (PPT)
Pain pressure threshold level will be assessed using the Baseline® Dolorimeter - 22 pound Capacity, a digital algometer.
Left-Right Judgment Task (LRJT)
In order to evaluate the participants' body awareness and laterality perception, the response time and accuracy rate regarding the direction of the images of the body will be measured with the Left-Right Judgment Task (LRJT) Recognise Online™ program.
Tampa Kinesiophobia Scale (TKS)
The Tampa Kinesiophobia Scale (TKS) consisting of 17 questions including work-related activities, re-injury and fear-avoidance parameters will be used to assess participants' fear of movement. A score \>37 indicates that the patient has symptoms of kinesiophobia.
Pain Catastrophizing Scale (PCS)
The PCS will be used to assess participants' feelings and thoughts about pain and pain catastrophizing. If the cut-off value of the pain catastrophizing scale is equal to or greater than 17, the values are considered high, and if it is less than 17, it is considered low.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Medipol University
Lead sponsor
The Scientific and Technological Research Council of Turkey
Collaborator
This trial is not recruiting at the moment. You can still explore other options: